Together, our study demonstrates a signaling axis involving STAT3/FGF7/AKT that mediates the crosstalk between CAFs and ccRCC tumor cells (Figure 6D), providing valuable insights for treating ccRCC patients. This evidence concerns the gene FGF7 and neoplasm.